[Amiodarone pulmonary toxicity]

Related Experiment Video

Updated: Oct 17, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

L Mazzei1, B Sposato, A Propati

  • 1I Unità Operativa di Broncopneumologia e Riabilitazione Respiratoria, Azienda Ospedaliera San Camillo-Forlanini, Roma.

Recenti Progressi in Medicina
|February 17, 2000
PubMed

Insights

A 75-year-old female developed amiodarone pulmonary toxicity despite low-dose, intermittent use. Diagnosis requires excluding other causes, and treatment involves drug withdrawal and steroids for rapid improvement.

Area of Science:

  • Pulmonology
  • Cardiology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic drug.
  • Pulmonary toxicity is a known but infrequent adverse effect of amiodarone.
  • Diagnosis of amiodarone-induced lung injury can be challenging.

Observation:

  • A 75-year-old female patient presented with respiratory symptoms after 6 months of low-dose amiodarone therapy (200 mg/daily, 5 days/week).
  • Radiological imaging revealed simultaneous alveolar and interstitial infiltrates.
  • Clinical and diagnostic features were not specific, necessitating exclusion of other potential causes.

Findings:

  • The patient's presentation was consistent with amiodarone pulmonary toxicity.
  • Diagnosis was established by excluding other potential etiologies for the observed pulmonary infiltrates.
  • Discontinuation of amiodarone and initiation of corticosteroid therapy led to significant clinical and radiological improvement.

Implications:

  • This case highlights that amiodarone pulmonary toxicity can occur even with low-dose, intermittent therapy.
  • Early recognition and prompt management, including drug withdrawal and steroid administration, are crucial for favorable outcomes.
  • Physicians should maintain a high index of suspicion for amiodarone-induced lung injury in patients on this medication, especially when pulmonary symptoms arise.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...